RecruitingPhase 2Phase 3NCT06643507
Evaluation of the Modified VISTA Technique Using ALB-PRF vs CTG in the Treatment of Multiple Miller Class III Recessions
Clinical Evaluation of the Modified VISTA Technique (M-VISTA )Using Albumin-platelet Rich Fibrin (Alb-PRF) Versus Connective Tissue Graft (CTG)in the Treatment of Multiple Miler Class III RT2 Recessions A Randomized Clinical Trial
Sponsor
Cairo University
Enrollment
26 participants
Start Date
Apr 20, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
treatment of miller class III RT2 gingival recession using modified vista technique using connective tissue graft vs albumin PRF
Eligibility
Min Age: 18 YearsMax Age: 60 Years
Inclusion Criteria1
- years old good oral hygiene
Exclusion Criteria1
- smokers patients with poor oral hygiene
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERConnective tissue graft
regenerative properties
BIOLOGICALALB-PRF
regenerative properties
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06643507
Related Trials
Changes of Soft Tissue Grafting: A Randomized Study
NCT056335111 location
Gingival Recession and Oral Health-related Quality of Life: A Cross-sectional Study
NCT075572771 location
Taking Measurements of a Gum Graft Site as it Heals
NCT073864571 location
Comparative Evaluation of Novel 3D Tunneling Technique Versus Modified Coronally Advanced Tunnel (MCAT) With Connective Tissue Graft in the Management of Multiple RT2 Gingival Recession
NCT075262591 location
Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
NCT068924961 location